CHRISTOPHER HANSON: Open Payments
NPI 1447514971 · CARBONDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 42 payments from 17 companies in 2025. Trend: 2023 $978 · 2024 $810 · 2025 $767
Food & beverage: $767
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $161 |
| Lilly USA, LLC | 7 | $122 |
| ABBVIE INC. | 5 | $89 |
| Indivior Inc. | 2 | $56 |
| Amgen Inc. | 3 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Corcept Therapeutics | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
Products named: MOUNJARO, Ozempic, VRAYLAR, SUBLOCADE, OTEZLA, Kerendia, FARXIGA, Korlym.
Industry payments across IL — which companies pay providers there.
